Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR | Market Cap | 132.40B -17.0% |
| Revenue (ttm) | 72.67B +13.2% |
| Net Income | 6.29B +4.0% |
| EPS | 32.07 +4.4% |
| Shares Out | n/a |
| PE Ratio | 21.05 |
| Forward PE | 16.56 |
| Dividend | 11.00 (1.70%) |
| Ex-Dividend Date | Jul 29, 2025 |
| Volume | 12,783 |
| Average Volume | 3,570 |
| Open | 680.35 |
| Previous Close | 694.30 |
| Day's Range | 666.00 - 691.20 |
| 52-Week Range | 635.30 - 1,107.80 |
| Beta | n/a |
| RSI | 45.75 |
| Earnings Date | May 8, 2026 |
About Alembic Pharmaceuticals
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspe... [Read more]
Financial Performance
In fiscal year 2025, Alembic Pharmaceuticals's revenue was 66.72 billion, an increase of 7.12% compared to the previous year's 62.29 billion. Earnings were 5.83 billion, a decrease of -5.26%.
Financial StatementsNews
Alembic Pharmaceuticals receives USFDA approval for Paroxetine Extended-Release Tablets
Alembic Pharmaceuticals Limited has secured final approval from the US Food & Drug Administration (USFDA) for its supplemental Abbreviated New Drug Application (sANDA) for Paroxetine Extended-Release ...
Pharma sector stocks today, March 27: Alembic falls 2.42%, Alembic Pharma down 1.58%, EMCURE Pharma surge 1.08%
The Indian pharmaceutical sector witnessed broad-based selling pressure on March 27, 2026, as the majority of pharma stocks traded in the red during early morning trade on both BSE and…
Pharma sector stocks today, March 23: Alembic Pharma down 2.24%, Ajanta Pharma falls 1.85%, Glenmark Pharma falls 1.98%
The pharmaceutical sector in India experienced a downturn on March 23, 2026, as reflected in early morning trading data from BSE and NSE around 9:29-9:30 AM IST. Most listed pharma…
Pharma sector stocks today, March 11: Natco Pharma falls 1.35%, Alembic Pharma surge 1.33%, Glenmark Pharma up 1.41%
The Pharmaceuticals sector stocks in India showed mixed performance on March 11, 2026, during early trading hours. Data is based on prices as of approximately 9:43 AM IST for BSE…
Alembic Pharmaceuticals incorporates Thailand subsidiary with 99.99% stake
Alembic Pharmaceuticals has incorporated a subsidiary in Thailand named Alembic Pharmaceuticals (Thailand) Co., Ltd, according to a regulatory filing on 9 March 2026. The company holds 99.99% sharehol...
Alembic Pharma reports first U.S. prescription sale of Pivya after commercial launch
Alembic Pharmaceuticals Limited has announced the first prescription-based sale of Pivya® (pivmecillinam) tablets in the United States following its recent commercial launch. The milestone marks Alemb...
Alembic Pharma secures USFDA final approval for Lamotrigine Orally Disintegrating Tablets
Alembic Pharmaceuticals Limited (Alembic) has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New...
Alembic Pharmaceuticals gets USFDA nod for Efinaconazole Topical Solution, 10%
Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug...
Pharma sector stocks down today, Feb 24: AstraZeneca Pharma falls 1.72%, Alembic Pharma down 1.38%, Gland Pharma drops 1.24%
The Indian pharmaceutical sector experienced a modest decline on February 24, 2026, amid broader market weakness. The S&P BSE HEALTHCARE...
Alembic Pharmaceuticals Ltd (BOM:533573) Q3 2026 Earnings Call Highlights: Strong Revenue ...
Alembic Pharmaceuticals Ltd (BOM:533573) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures
Q3 2026 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Q3 2026 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Alembic Pharmaceuticals gets USFDA final approval for Carbidopa, Levodopa and Entacapone tablets
Alembic Pharmaceuticals Limited has announced a major regulatory milestone after securing final approval from the US Food and Drug Administration...
Pharma sector stocks today, Feb 6: Concord Biotech jumps 4.61%, Alembic Pharma falls 4%, Marksans Pharma down 3.48%
The Indian pharmaceutical sector displayed mixed performance in early trading on February 6, 2026, as of approximately 10:00 AM IST....
Alembic Pharma Q3 Results: Revenue jumps 10.8% YoY to Rs 1,876 crore, net profit falls 3.9%
Alembic Pharmaceuticals reported its consolidated Q3 results with steady operational growth, even as net profit declined on account of an...
Alembic Pharma receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%
Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food and Drug Administration for its...
Pharma sector stocks today, Jan 27: Syngene down 7%, Natco Pharma falls 2.31%, Alembic Pharma down 1%
Pharma stocks showed mixed movement in early trade today with selective buying in mid and small-cap names while several large-cap...
Pharma sector stocks fall today: Cipla drops 1.52%, Divi’s Laboratories falls 0.78%, Alembic Pharma down 0.52%
The Indian pharmaceutical sector experienced a downturn on January 19, 2026, with many listed pharma stocks trading lower in early...
Pharma sector stocks today: Sun Pharma falls 1.43%, Ipca Labs down 1.32%, Alembic Pharma drops 1.08%
The Indian pharmaceutical sector showed mixed performance on January 16, 2026, as of around 10 AM IST. Broader market indices...
Alembic Pharmaceuticals secures USFDA tentative approval for Bosutinib 400 mg tablets
Alembic Pharmaceuticals Limited has announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for...
Alembic Pharma gets USFDA final approval for Travoprost Ophthalmic Solution
Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug...
Alembic Pharmaceuticals secures USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3%
Alembic Pharmaceuticals has added another key approval to its growing US portfolio, announcing that the US Food & Drug Administration...
Alembic Pharma shares rise over 2% after USFDA nod for Diltiazem Hydrochloride Tablets
Alembic Pharmaceuticals’ stock inched over 2% higher after the company announced that it has secured final approval from the US...
Alembic Pharma gets USFDA final nod for Diltiazem Hydrochloride Tablets
Alembic Pharmaceuticals has received final approval from the USFDA for its Abbreviated New Drug Application for Diltiazem Hydrochloride Tablets USP...
Alembic Pharma secures final USFDA approval for Dexlansoprazole DR capsules
Alembic Pharmaceuticals announced today that it has secured final approval from the US Food & Drug Administration (USFDA) for its...
Alembic Pharmaceuticals receives USFDA final approval for Dasatinib Tablets across six strengths
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (USFDA) for its...